SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014)
SELLAS Life Sciences (SLS) posted quarterly Capital Leases of $17000.0 for Q3 2014, down 43.33% year-over-year from $30000.0 in Q3 2013, and down 10.53% quarter-over-quarter from $19000.0 in Q2 2014.
SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Capital Leases for 5 consecutive years, with $17000.0 the latest figure, recorded in Q3 2014.
- In Q3 2014, Capital Leases fell 43.33% year-over-year to $17000.0; the TTM figure through Sep 2014 stood at $17000.0 (down 43.33% YoY), while the FY2013 annual figure was $26000.0, down 49.02% from the prior year.
- Capital Leases slipped to $17000.0 in Q3 2014 per SLS's latest filing, from $19000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $51000.0 in Q3 2012 and bottomed at $10000.0 in Q2 2011.
- Historically, Capital Leases has averaged $29571.4 across 5 years, with a median of $28000.0 in 2013.
- Annual changes were most pronounced in 2012 — Capital Leases surged 264.29% — and 2014, when it tumbled 54.9%.
- SELLAS Life Sciences' Capital Leases stood at $20000.0 in 2010, then soared by 60.0% to $32000.0 in 2011, then jumped by 59.38% to $51000.0 in 2012, then slumped by 49.02% to $26000.0 in 2013, then tumbled by 34.62% to $17000.0 in 2014.
- Business Quant data shows SLS's Capital Leases at $17000.0 in Q3 2014, $19000.0 in Q2 2014, and $23000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 26,000.00 |
| Sep 30, 2013 | 30,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Mar 31, 2013 | 51,000.00 |
| Dec 31, 2012 | 51,000.00 |
| Sep 30, 2012 | 51,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 32,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 20,000.00 |